Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market anticipated reaching up to USD 0.7 Billion by 2035
An extensive study of propelling opportunities in, “Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size, Share & Trends Analysis Report by Component (Pumps, Oxygenators, Controllers, Cannulas, Accessories, Others), by Modality (Veno-Venous (VV), Veno-Arterial (VA), Arterio-Venous (AV)), Age Group, Technology, Patient Type, Application, End User and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A comprehensive report of growing market landscapes in the extracorporeal membrane oxygenation (ECMO) machine sector uncovering key growth drivers including niche market leadership, technology-enabled distribution, and increasing consumer needs supporting extracorporeal membrane oxygenation (ECMO) machine potential to scale globally.
Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2035:
According to the report, the global extracorporeal membrane oxygenation (ECMO) machine market is anticipated to grow from USD 0.4 Billion in 2025 to USD 0.7 Billion in 2035 at a CAGR of 4.3% during the forecast. The ECMO machine market is growing rapidly, driven by enhanced awareness and use of the devices globally, especially during the pandemic and preceding COVID-19 effects, and demonstrated applications in cardiac and respiratory failure. Growth in the number of ECMO centers and with the stated increase in ECMO transport teams, the use addresses increased interest in both higher-resourced and growing-based healthcare systems.
Notably, systems are being miniaturized and made more autonomous to limit the number of actions while increasing safety in critical care environments. Hybrid ECMO systems with an integrated artificial intelligence monitoring aspect are in testing at a few tertiary care centers in the US and Swedon to initiate and provide predictive alerts on clot formation, interruptions in flow, and performance of oxygenator performance. A number of startups are also exploring wearable ECMO prototypes with potential bridge-to-transplant applications.
Countries such as Brazil and Vietnam have tested the use of mobile ECMO in remote ICUs utilizing public-private partnerships, engaging centralized perfusionist command centers based on tele-ICU platforms. While, leading Canadian and Japanese institutions develop and provide simulation-based training on ECMO with augmented and virtual reality focus given the shortage of trained perfusionists.
Moreover, the disconnection between market regulations and mandates, combined with access to ongoing specialist support, will be continuous challenges. There are also still ethical, economic, and efficacy considerations for continuous ECMO. The future of extracorporeal life support will be driven by interoperability onto ICU data systems and semi-automated ECMO work processes developed by industry.
“Key Driver, Restraint, and Growth Opportunity Defining the Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market”
The primary driver of the ECMO machine market is the greater awareness of ECMO as a life-saving treatment for severely compromised patients with cardiac or respiratory dysfunction. The importance of clinical value was recognized globally during COVID-19, with many hospitals/hospital systems investing in critical care during this pandemic. As technology advances, features such as automated controls, enhanced sensor integration, and user-friendly interfaces and display panels will reduce operational complexity, allowing continuous adoption of ECMO across ICUs (intensive care units) around the world, particularly in developed countries.
However, economic and operator resource restrictions limit the feasibility for hospitals to adopt ECMO and contribute to limiting development. Operating ECMO machines is costly, particularly due to equipment and ongoing operational costs (including highly trained perfusionist resources and 24-hr access to qualified episodic clinical resources). The extremely high and intensive resource and budget requirements limit the penetration of ECMO technology to tertiary hospitals with significant resource requirements or in high-resourced academic hospitals.
Furthermore, a unique opportunity for long-range growth in the ECMO machine market comes from developing small, portable, or transportable ECMO systems. Development and miniaturization of ECMO machines could allow for the use of portable ECMO systems outside acute-care hospitals in the pre-hospital or rural critical care setting. Companies are interested in investing in portable systems that can support a miniaturized, lightweight, rapid-deployment ECMO systems.
"Impact of Global Tariff Policies on the Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Growth and Strategy"
The market for ECMO machines has shown considerable sensitivity to global tariffs because they often represent a complex assembly of highly priced components, with many of these blocks coming from various locations wielding different tariff laws. Tariffs on medical devices or electronic components, especially prevalent in many aspects of U.S.-China and EU-Asia tensions, have increased the effective prices for ECMO system manufacturers, and subsequently healthcare system implementation.
Additionally, the tariff issue has limited adoption of ECMO devices in price-sensitive areas and slowed the procurement of ECMO systems for public health. The leading ECMO system manufacturers have made moves to change this landscape by relocating their assembly to countries with favorable trading conditions while also investing in some form of localized manufacturing in large healthcare market dimensions, like India and the U.S.
Expansion of Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market
"Portable Systems, AI Integration, and Critical Care Demand Accelerate Global ECMO Machine Market Growth"
Regional Analysis of Extracorporeal Membrane Oxygenation (ECMO) Machine Market
Key players in the global extracorporeal membrane oxygenation (ECMO) machine market include prominent companies such as Abbott Laboratories, Abiomed Inc., ALung Technologies, Inc., Andocor N.V., Cardiohelp (Getinge), Eurosets S.r.l., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, LivaNova PLC, MC3 Cardiopulmonary, Medos Medizintechnik AG, Medtronic plc, Microport Scientific Corporation, Nipro Corporation, OriGen Biomedical, Inc., Senko Medical Instrument Mfg. Co., Ltd., Spectrum Medical, Terumo Corporation, Xenios AG (a Fresenius Medical Care Company), and other key players, along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.
The Extracorporeal Membrane Oxygenation (ECMO) Machine Market has been segmented as follows:
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Component
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Modality
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Age Group
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Technology
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Patient Type
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Application
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by End User
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Region
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact US
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation